Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix
Authors:
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 144 (1) , 46-50
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II StudyClinical Lung Cancer, 2013
- Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group studyEuropean Journal of Cancer, 2012
- Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical documentGynecologic Oncology, 2011
- Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology GroupJournal of Thoracic Oncology, 2010
- Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patientsAmerican Journal of Obstetrics and Gynecology, 2010
- Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaCancer Biology & Therapy, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic studyInternational Journal of Gynecological Cancer, 2005
- Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrenceGynecologic Oncology, 2004